RumeyzaKazancioglu Bezmialem Vakif UniversityTürkiye

She graduated from Istanbul University, Istanbul Faculty of Medicine in 1991, and completed her Internal Medicine Residency and Nephrology fellowship at the same faculty until 2001. She is a former ISN fellow, currently working at Bezmialem Vakif University School of Medicine Division Nephrology. Prof. Kazancıoğlu has published many national and international articles, books and book chapters. Her main interests are in PD, disaster nephrology, CKD and ESKD.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Hands on Big Data Mining for the Nephrologist in 2024 HeatherAscani Chairperson University of MichiganUnited States KatherineTuttle Chairperson University of Washington School of Medicine, Division of NephrologyUnited States MatthiasKretzler Chairperson University of MichiganUnited State Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse VijiNair Speaker University of MichiganUnited States Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI MatthiasKretzler Speaker University of MichiganUnited State The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany Panel Discussion Hall C1
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) AgnesFogo Chairperson United States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria Hall A
12:15 p.m. 1:15 p.m.	Transplant Tourism in My Clinic: What Should I Do? ISN-DICG Joint Session Domingo Casadei Chairperson drdomingocasadei@gmail.com VivekanandJha Chairperson vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia How to Achieve Transparent and Regulated Organ Donation and Transplantation Maria AmaliaMatamoros Speaker amatamoros@cehcr.comCosta Rica Non-resident Foreigners in Argentina: Legal Framework to Prevent Transplant Tourism LilianaBisigniano Speaker lbisigniano@incucai.gov.arLiliana Bisigniano MDArgentina How to Handle Cases of Presumed Transplant Tourism KenSakai Speaker kensakai@med.toho-u.ac.jpDepartment of Nephrology, Toho University Omori Medical CenterJapan Q and A Hall C1
4:30 p.m. 5:30 p.m.	New Developments in CKD Epidemiology Research MaartenTaal Chairperson University of NottinghamUnited Kingdom RobertoPecoits Filho Chairperson Arbor Research Collaborative for HealthUnited States Big Data Lab Patient-reported Outcome Measures: How Do Patients Experience CKD? AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada Trial Simulation Using Observational Data AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgArbor Research Collaborative for HealthUnited States Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges DorotheaNitsch Speaker dorothea.nitsch@lshtm.ac.ukLondon School of Hygiene & Tropical MedicineUnited Kingdom Q and A Hall C4

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	Hot Digests of Kidney Inflammation and Immunity: ISN-JSN Joint Session AlejandraQuevedo Smuclir Chairperson alejandra.s.quevedo@gmail.comSANArgentina CarmenTzanno Branco Martins Chairperson tzanno@gmail.comSLANH, ISNBrazil SaoriNishio Chairperson saorin@med.hokudai.ac.jpJapan Update of Glomerulonephritis FernandoFervenza Speaker fervenza.fernando@mayo.eduMayo ClinicUnited States Inflammation and Metabolic Kidney Disease JunWada Speaker junwada@okayama-u.ac.jpOkayama UniversityJapan A Novel Treatment Targeting Kidney Inflammation Maria JoséSoler Romeo Speaker Hospital del Vall d´HebronSpain Controlling Kidney Inflammation Through the Nervous System ShinjiTanaka Speaker shitanaka@m.u-tokyo.ac.jpDivision of Nephrology and Endocrinology, the University of Tokyo HospitalJapan Q and A Hall C3
10:30 a.m. 11 a.m.	Nephrology in Jeopardy: A Sustainable Kidney Care Quiz BrendanSmyth Spotlight Chairperson brendan.smyth@sydney.edu.auAustralia LetiziaDe Chiara Spotlight Chairperson letizia.dechiara@unifi.itDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence Italy UgochiOnu Spotlight Chairperson ugochionu2008@gmail.comNigeria Spotlight Stage 1 (exhibition hall)
11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala MegJardine Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comhttps://research.ibm.com/Israel Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A
12:15 p.m. 1:15 p.m.	Natural and Man-made Disasters and Kidney Care. ISN-ERA Special Lecture IfeomaUlasi Chairperson ifeoma.ulasi@unn.edu.ngCollege of Medicine, University of NigeriaNigeria VictorFrajewicki Chairperson vfraje@clalit.org.ilDepartment of Nephrology and Hypertension, Carmel Medical Center, HaifaIsrael The Next Pandemic - What Has the Nephrology Community Learned From COVID-19? RaulLombardi Speaker lombardi.raul2@gmail.comDepartment of Nephrology, Schoole of Medicine, UniUruguay Challenges in Nephrological Care During Difficult Situations: Lessons From Venezuela LorendizRonca Chacare Speaker lorendiz.ronca@gmail.comSociedad Venezolana de NefrologíaVenezuela Kidney Care During Earthquakes: Lessons Learned From Turkey RumeyzaKazancioglu Speaker drkazancioglu@yahoo.comBezmialem Vakif UniversityTürkiye Provision of Renal Care During Man-made Disasters and Armed Conflicts: A Challenging Proposition RobertNajem Speaker robertnajem@yahoo.frLebanese University, Faculty of Medical Sciences.Lebanon Q and A Hall D
3 p.m. 4 p.m.	Transplant-Onconephrology DarioRoccatello Chairperson dario.roccatello@unito.itItaly GayatriNair Chairperson gnair1@northwell.eduNorthwell Health, NYUnited States MarianoArriola Chairperson marianoarriola@hotmail.comSAT, SAN, Facultad de Medicina (UNL)Argentina Use of Immunotherapy in Patients With Organ Transplants NaokaMurakami Speaker nmurakami1@bwh.harvard.eduBrigham and Women\'s Hospital, Harvard Medical SUnited States Transplantation Outcomes in Recipients with History of Cancer GermaineWong Speaker University of SydneyAustralia Novel Strategies for Enhanced Organ Preservation during Machine Perfusion TobiasHuber Speaker University Medical Center Hamburg-EppendorfGermany Q and A Hall E
3:50 p.m. 5:40 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Advancing Accessibility in Kidney Health - Towards Sustainable Solutions IfeomaUlasi Chairperson ifeoma.ulasi@unn.edu.ngCollege of Medicine, University of NigeriaNigeria Nelson AlbertoCastro Moderator trischt19@gmail.comArgentina Accessibility to CKD Diagnosis: Focus on CKDu (Chronic Kidney Disease of Unknown Origin) and Advancements in Diagnostic Approaches RamonGarcia Trabanino Speaker rgtrab@gmail.comSLANHEl Salvador Latin American Dialysis and Renal Transplantation Registry: Updates and Progress MariaGonzalez Speaker registro@slanh.netSLANHUruguay Special Situations in Argentina: Addressing the Challenges Faced by Individuals on Dialysis Without a Diagnosis in the Argentinian Registry GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina Cardiovascular and Renal Risk Factors in Argentinian First Nations: A Study of Qom and Wichi Indigenous Groups Maria Eugenia VictoriaBianchi Speaker bianchimaria@me.comISN. SAN.Argentina Accessibility to Substitution Treatment in Latin America AlejandroFerreiro-Fuentes Speaker aferreirofuentes@gmail.comCentro de Nefrología. Universidad de la República,Uruguay Accessibility to Programs of Prevention, and Early Detection and Treatment of Kidney Disease in Latin America Alfonso MartinCueto Manzano Speaker a_cueto_manzano@hotmail.comUnidad de Investigación Médica en Enfermedades RenMexico Break Panel Discussion and Closing Remarks by Valerie Luyckx, University of Zurich, Switzerland Hall C2
4:30 p.m. 5:30 p.m.	Designing Smart Clinical Trials DebbieGipson Chairperson debbie.gipson@nih.govNational Institutes of Health/NIDDKUnited States JonathanBarratt Chairperson University of Leicester, Leicester, UKUnited Kingdom Patients Subphenotyping: The Example of Diabetic Kidney Disease John CijiangHe Speaker cijiang.he@mssm.eduIcahn School of Medicine at Mount SinaiUnited States Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease LauraMariani Speaker University of MichiganUnited States Targeted Approaches in Clinical Trial Design HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall D

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10:30 a.m.	Hi Aldo, What's New? Advances in Aldosterone in Health and Disease CarlosSchreck Chairperson carlos.schreck@gmail.comHospital Italiano de Buenos Aires- NephrologyArgentina KellyHaughton Chairperson kidneydoctorpanama@gmail.comSLANH, PanamaPanama Why Are Fewer Than I% Of Hypertensive Patients Ever Screened For Primary Aldosteronism? John Funder Speaker John.Funder@hudson.org.auThe Hudson Institute of Medical Research Clayton 3168 Victoria Australia; Monash University, Clayton 3600 Victoria AustraliaAustralia Aldosterone and Disease JordanaCohen Speaker jco@pennmedicine.upenn.eduUniversity of PennsylvaniaUnited States New Trials Using Aldosterone Synthese Blockade MichelAzizi Speaker michel.azizi@aphp.frUniversité Paris Cité, Hypertension department, HôFrance Targeting MR for Heart and Kidney Protection HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall E
9 a.m. 10:30 a.m.	Clinical Management of Glomerulonephritis (GN) Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina Updates on IgAN Management HernánTrimarchi Speaker HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina Membranous GN Classification and Management PierreRonco Speaker Hôpital TenonFrance MPGN Updates SanjeevSethi Speaker Mayo ClinicUnited States Managing Vasculitis RobertaFenoglio Speaker roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly Q and A Hall A
11 a.m. 12:15 p.m.	Plenary Session 4: Insights into SGLT2 Inhibitors: A Story of Discovery (Ele Ferrannini, Italy) AlessiaFornoni Chairperson United States Prof LizLightstone Chairperson Imperial College LondonUnited Kingdom MasaomiNangaku Chairperson mnangaku@m.u-tokyo.ac.jpJapan Acceptance Speech: Bywaters Award MotokoYanagita Speaker Kyoto UniversityJapan Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture EleFerrannini Speaker eleferrannini@gmail.comUniversity of PisaItaly ELP2 Graduation MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan Hall A
12:30 p.m. 1:30 p.m.	Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? MarceloOrías Chairperson marcelo.orias@gmail.comArgentina MarkSarnak Chairperson msarnak@tuftsmedicalcenter.orgTufts Medical CenterUnited States Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS TaraChang Speaker tichang@stanford.eduStanford UniversityUnited States Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS JordanaCohen Speaker jco@pennmedicine.upenn.eduUniversity of PennsylvaniaUnited States Hall A